← All Journey Medical CORP filings

Journey Medical CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
DERM
Journey Medical CORP
10-K: Journey Medical Corp Reports 2024 Annual Results, Highlights Emrosi Approval
Journey Medical Corp's 2024 10-K filing details the company's financial performance, strategic initiatives, and the FDA approval of Emrosi for rosacea treatment.
NASDAQ
DERM
Journey Medical CORP
10-K: Journey Medical Corporation Reports 2023 Financial Results and Provides Business Update
Journey Medical Corporation's 2023 annual report details financial performance, strategic initiatives, and regulatory progress, including a new credit facility and a license agreement.